Literature DB >> 11125312

Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.

C Ribbens1, B André, O Kaye, M J Kaiser, V Bonnet, D de Groote, N Franchimont, M G Malaise.   

Abstract

The assessment of cytokines and their soluble receptors in the synovial fluid (SF) of inflammatory arthropathies may be useful in studying pathogenetic and immunoregulatory mechanisms underlying different diseases. The aim of this work was to study the cytokine network occurring in inflammatory arthropathies and to identify a cytokine profile which is characteristic of an immune-mediated synovitis. Levels of IL-12, as well as IL-4, IL-8, IL-10, IFN-gamma, sCD25, TNF-alpha and its soluble receptors were measured in the SF of various arthropathies, i.e. non-inflammatory arthropathies: "control" meniscus pathology (n = 21), osteoarthritis (n = 22) and chronic crystal arthritis (n = 9); a non-immune inflammatory arthropathy: acute crystal arthritis (n = 11); 2 immune inflammatory arthropathies: reactive arthritis (ReA) (n = 23) and rheumatoid arthritis (RA) (n = 44). SF levels of IL-10, TNF-alpha and sTNF-RII were found to be increased in the three inflammatory arthropathies compared to the "control" meniscus group. Within the inflammatory group, acute crystal arthritis was characterized by a significantly higher sTNF-RI/TNF-alpha ratio and ReA by a significantly lower sTNF-RII/TNF-alpha ratio compared to the two other diseases. The two immune arthropathies, RA and ReA, were characterized by increased SF levels of IL-12, sCD25 and of the sTNF-RII/sTNF-RI ratio. ReA differed however from RA by showing lower IL-8 and IL-4 levels, higher IFN-gamma levels and a higher IL-12/IL-10 ratio, suggesting a more prevalent Th1 profile in ReA SF. Our data indicate that the measurement of SF cytokines and soluble receptors may discriminate between each inflammatory arthropathy and might be useful in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11125312

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  5 in total

1.  Spondyloarthropathies: Targeted therapy for psoriatic arthritis.

Authors:  Dafna D Gladman
Journal:  Nat Rev Rheumatol       Date:  2009-05       Impact factor: 20.543

2.  Exercise increases interleukin-10 levels both intraarticularly and peri-synovially in patients with knee osteoarthritis: a randomized controlled trial.

Authors:  Ida C Helmark; Ulla R Mikkelsen; Jens Børglum; Anders Rothe; Marie C H Petersen; Ove Andersen; Henning Langberg; Michael Kjaer
Journal:  Arthritis Res Ther       Date:  2010-07-01       Impact factor: 5.156

Review 3.  Rheumatiod Arthritis: An Updated Overview of Latest Therapy and Drug Delivery.

Authors:  Disha Kesharwani; Rishi Paliwal; Trilochan Satapathy; Swarnali Das Paul
Journal:  J Pharmacopuncture       Date:  2019-12-31

4.  Soluble cytokine receptor levels in aqueous humour of patients with specific autoimmune uveitic entities: sCD30 is a biomarker of granulomatous uveitis.

Authors:  Ahmed M Abu El-Asrar; Nele Berghmans; Saleh A Al-Obeidan; Priscilla W Gikandi; Ghislain Opdenakker; Jo Van Damme; Sofie Struyf
Journal:  Eye (Lond)       Date:  2019-12-05       Impact factor: 3.775

Review 5.  On the role of sIL-2R measurements in rheumatoid arthritis and cancers.

Authors:  Anna Maria Witkowska
Journal:  Mediators Inflamm       Date:  2005-08-14       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.